For patients with advanced oropharyngeal cancer, proton therapy may beat photon radiotherapy in terms of overall survival and ...
Hosted on MSN
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patient-reported quality of life (QoL) was similar between ...
Intensity-modulated proton therapy (IMPT) matched intensity-modulated radiation therapy (IMRT) for progression-free survival in a phase III trial of oropharyngeal cancer. Patients receiving proton ...
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people ...
Proton Therapy reduces the risk of a second cancer diagnosis by 69% versus other forms of radiation treatment according to a paper recently released by a team from Stanford University. The study ...
For patients with intermediate- or low-risk localized prostate cancer, intensity-modulated radiation therapy (IMRT) and proton beam therapy are both safe and effective options, according to results of ...
Louvain-La-Neuve, Belgium, December 15, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy ...
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback